Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A buffered local anesthetic solution that combines lidocaine (an anesthetic), epinephrine (a vasoconstrictor), and sodium bicarbonate (a buffering agent). The addition of sodium bicarbonate raises the pH of the acidic lidocaine-epinephrine solution to a more physiologic range, which significantly reduces the burning sensation during infiltration and speeds up the onset of anesthesia. The epinephrine component helps to prolong the anesthetic effect and reduce bleeding at the injection site. This combination is commonly used for office-based procedures, particularly in dermatology and emergency medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine + epinephrine + sodium bicarbonate.